CG
SNDX icon

Cutler Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Cutler Group’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,300
Closed -$7K – 6284
2021
Q1 		$7K Sell
2,300
-7,200
-76% -$163K ﹤0.01% 4145
2020
Q4 		$4K Buy
+9,500
New +$197K ﹤0.01% 3829
2019
Q3 		– Sell
-2,800
Closed -$3K – 4642
2019
Q2 		$3K Buy
+2,800
New +$20.4K ﹤0.01% 3420
2018
Q4 		– Sell
-2,600
Closed -$5K – 4534
2018
Q3 		$5K Buy
+2,600
New +$18.5K ﹤0.01% 3072

Other funds holding SNDX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return